Published During September 7th – 9th, 2022, Mr. Thaweesak Chieochansin, Ph.D., a senior researcher from the Division of Molecular Medicine, Department of Research, Faculty of Medicine Siriraj Hospital, Mahidol University, attended an international conference “European School of Hematology’s 6th Translational Research Conference-Multiple Myeloma” in France and delivered a research poster presentation on the topic “Molecular Dynamics Simulation Reveals the Binding Ability of Predicted New York Esophageal Squamous Cell Carcinoma-1 (NY-ESO-1) Peptide Loaded on HLA-A*02:01 for Potential Used as Cancer Vaccine to Treat Multiple Myeloma.”
This conference is intended to emphasize cutting-edge basic and clinical research and future treatment prospects for multiple myeloma. Intentionally, ample time is allocated for in-depth scientific discussion and interaction. The conference allowed for informal scientific exchange with the world’s foremost experts in treating multiple myeloma. The most recent treatment guidelines and inside information about the treatment have been provided in depth by experts who have conducted numerous clinical studies and collected real-world data. Moreover, the conference allowed participants and experts to establish connections. It will be of great benefit not only to basic research but also to the clinical care of Siriraj Hospital’s multiple myeloma patients.
